Lead Pharma, Sanofi to research inflammatory diseases

Lead Pharma Holding BV, a Dutch company with a novel approach to drug discovery, has entered into a research collaboration and licensing agreement with Sanofi SA to identify small molecule compounds that moderate pro-inflammatory proteins.